Bioceres Crop Solutions Corp. (BIOX)
NASDAQ: BIOX · Real-Time Price · USD
6.19
+0.10 (1.64%)
Dec 20, 2024, 4:00 PM EST - Market closed
Bioceres Crop Solutions Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for BIOX stock have an average target of 13.9, with a low estimate of 9.50 and a high estimate of 21. The average target predicts an increase of 124.56% from the current stock price of 6.19.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 13, 2024.
Analyst Ratings
The average analyst rating for BIOX stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $10 → $9.5 | Strong Buy | Maintains | $10 → $9.5 | +53.47% | Nov 13, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $16 → $13 | Buy | Maintains | $16 → $13 | +110.02% | Oct 21, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $13 → $10 | Strong Buy | Maintains | $13 → $10 | +61.55% | Oct 17, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $17 → $13 | Strong Buy | Maintains | $17 → $13 | +101.94% | Sep 11, 2024 |
| Roth MKM | Roth MKM | Strong Buy Maintains $15 → $13 | Strong Buy | Maintains | $15 → $13 | +110.02% | Sep 11, 2024 |
Financial Forecast
Revenue This Year
478.99M
from 464.83M
Increased by 3.05%
Revenue Next Year
529.43M
from 478.99M
Increased by 10.53%
EPS This Year
0.26
from 0.05
Increased by 405.67%
EPS Next Year
0.39
from 0.26
Increased by 50.00%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 501.9M | 567.0M | 600.0M | ||
| Avg | 479.0M | 529.4M | 582.8M | ||
| Low | 456.0M | 488.1M | 560.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 8.0% | 18.4% | 13.3% | ||
| Avg | 3.0% | 10.5% | 10.1% | ||
| Low | -1.9% | 1.9% | 5.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.45 | 0.48 | 0.89 | ||
| Avg | 0.26 | 0.39 | 0.87 | ||
| Low | 0.08 | 0.29 | 0.83 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 783.6% | 86.9% | 130.3% | ||
| Avg | 405.7% | 50.0% | 123.7% | ||
| Low | 53.4% | 13.8% | 114.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.